# Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

> **NCT06555614** · — · RECRUITING · sponsor: **DOF Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Breast Cancer Female
- Breast Reconstruction

## Interventions

- **OTHER:** Acellular Dermal Matrix(ADM)

## Key facts

- **NCT ID:** NCT06555614
- **Lead sponsor:** DOF Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-13
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06555614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06555614, "Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06555614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*